| Dokumendiregister | Andmekaitse Inspektsioon |
| Viit | 2.2.-5/26/4d-1 |
| Registreeritud | 10.02.2026 |
| Sünkroonitud | 11.02.2026 |
| Liik | Sissetulev kiri |
| Funktsioon | 2.2 Loa- ja teavitamismenetlused |
| Sari | 2.2.-5 Määratud andmekaitsespetsialist ja isikuandmete kaitse üldmääruse art 27 kohased teavitused |
| Toimik | 2.2.-5/2026 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | Viatris OÜ |
| Saabumis/saatmisviis | Viatris OÜ |
| Vastutaja | Maarja Kirss (Andmekaitse Inspektsioon, Koostöö valdkond) |
| Originaal | Ava uues aknas |
Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. |
Lugupeetud Eesti järelevalveasutus,
Käesolevaga teavitame Teid, et vastavalt Euroopa Parlamendi ja nõukogu määruse (EL) 2016/679 artikli 37 lõikele 7 on Viatris OÜ vabatahtlikult määranud andmekaitseametniku ning edastab käesolevaga lisatud kirjas andmekaitseametniku kontaktandmed.
Andmekaitseametnikuga võib ühendust võtta kõigis küsimustes, mis on seotud isikuandmete töötlemise ning andmesubjekti õiguste teostamisega.
Palume võtta meiega ühendust, kui vajate täiendavat teavet.
This email message and any attachments are for the exclusive use of the intended addressee(s). This message may contain confidential, privileged and/or proprietary information, and unauthorized review, use or distribution by persons other than the intended addressee(s) is strictly prohibited and may be unlawful. Unintended transmission does not waive any privilege including attorney-client, attorney work product or claims to confidentiality. If you received this email in error or it was forwarded from recipients who received it in error, please contact me by return message and immediately destroy all electronic, paper and other versions of this message. Viatris, Inc. and its affiliates and subsidiaries process your personal data in order to interact with you in the context of our business activities. Depending on your location, you may have the right to access, delete, restrict, edit, move, or object to our use of your personal data. You may also have the right to report concerns to the authority responsible for data protection where you live or work. You can learn more about our data protection practices by accessing our Privacy Policy (https://www.viatris.com/en-us/privacy-policy). By accessing this link, you can learn about the personal data we process, how it is shared, where it is stored, to where it may be transferred, for how long we keep it, and how to contact our Data Protection Officer. For questions or concerns related to data protection, please email [email protected]. |
|||
|
Please think before you print. |
|
View in other languages. |
Global Data Privacy 1000 Mylan Boulevard Canonsburg, PA 15317
To: Supervisory Authority Data Protection Office January 31, 2023 Appointment of EU Data Protection Officer Dear Supervisory Authority, In accordance with Article 37(7) of the GDPR, please find below the Data Protection Officer that will be appointed for the European undertakings outlined in Appendix 1. The contact details for the Data Protection Officer are: Tracey Basler Head of Global Privacy, 1000 Mylan Boulevard, Canonsburg, PA 15317, United States e-mail: [email protected] The EU-based contact supporting the Data Protection Officer is: Joanna Zielinska-Bertier Senior Data Privacy Manager for Europe 1 rue de Turin 69007 Lyon, France e-mail : [email protected] Best regards,
X Tracey Basler Head of Global Privacy
Tracey Basler (Oct 10, 2023 15:40 EDT) Tracey Basler
Appendix 1
Jurisdiction Company Name Austria Arcana Arzneimittel GmbH Austria Mylan Österreich GmbH Belgium Pfizer Innovative Supply Point International BV Belgium Upjohn SRL Belgium Viatris BV
Belgium Viatris GX BV Belgium Viatris Healthcare NV Bosnia and Herzegovina Viatris BH, društvo sa ograničenom odgovornošću za trgovinu i usluge Bulgaria Mylan EOOD Croatia Viatris Hrvatska d.o.o. Cyprus Agila Specialties (Holdings) Cyprus Limited (in liquidation) Cyprus Agila Specialties Americas Limited (in liquidation) Cyprus Onco Laboratories Limited Czech Republic MEDA Pharma s.r.o. Czech Republic Mylan Pharmaceuticals s.r.o. Czech Republic Viatris CZ s.r.o. Denmark Mylan ApS Denmark Viatris ApS England & Wales Agila Specialties Investments Ltd England & Wales Generics (U.K.) Ltd. England & Wales Mylan Holdings Ltd. England & Wales Mylan Pharma UK Limited England & Wales Mylan Products Limited England & Wales Upjohn UK 2 Ltd. England & Wales Upjohn UK Limited England & Wales Viatris UK Healthcare Limited Estonia Viatris OÜ
Finland Viatris Oy France Laboratoires Madaus S.A.S.
France Meda Holding S.A.S. France Meda Manufacturing S.A.S. France Meda Pharma S.A.S. France Mylan Generics France Holding S.A.S. France Mylan Laboratories S.A.S. France Rottapharm S.A.S. France VIATRIS HEALTHCARE France VIATRIS MEDICAL France VIATRIS SANTE France VIATRIS UP Germany Erste Madaus Beteiligungs GmbH
Germany MEDA Germany Holding GmbH Germany MEDA Manufacturing GmbH Germany MWB Pharma GmbH Germany Mylan dura GmbH Germany Pharmazeutische Union GmbH Germany PharmLog Pharma Logistik GmbH Germany ROTTAPHARM | MADAUS GmbH Germany VIATRIS GmbH Germany Viatris Pharma GmbH Germany Zweite Madaus Beteiligungs GmbH Greece Viatris Hellas Limited Liability Company Hungary Viatris Healthcare Kft. Hungary Viatris Services Kft. Ireland McDermott Laboratories Limited Ireland Meda Health Sales Ireland Limited Ireland Mylan IRE Healthcare Limited Ireland Mylan Ireland Limited Ireland Mylan Pharma Acquisition Limited Ireland Mylan Pharmaceuticals Limited Ireland Mylan Teoranta Ireland Rottapharm Limited Ireland Upjohn Manufacturing Ireland Unlimited Ireland Viatris Healthcare Limited Ireland Viatris Limited Italy DERMOGROUP S.r.l. Italy Meda Pharma S.p.A. Italy Mylan S.p.A. Italy Rottapharm S.p.A.
Italy Viatris Italia S.r.l. Italy Viatris Pharma S.r.l. Latvia SIA "Meda Pharma" Latvia Viatris SIA Lithuania Viatris UAB Netherlands Meda Pharma B.V. Netherlands Mylan B.V. Netherlands Mylan Group B.V. Netherlands Mylan Healthcare B.V. Netherlands Mylan I B.V. in liquidatie Netherlands Mylan II B.V. Netherlands Upjohn Belgium B.V. Netherlands Upjohn EESV Netherlands Upjohn Europe Holdings B.V. Netherlands Upjohn Export B.V.
Netherlands Upjohn Finance B.V. Netherlands Upjohn Global Holdings B.V. Netherlands Upjohn Group Holdings B.V. Netherlands Upjohn Intermediate Holdings B.V. Netherlands Upjohn International Holdings B.V. Netherlands Upjohn Vietnam Dutch B.V. Netherlands Viatris Enterprise Holding B.V. Netherlands Viatris Ireland Holding B.V. Netherlands Viatris Manufacturing B.V. Netherlands Viatris Mexico Holding B.V. Netherlands Viatris Netherlands B.V. Netherlands Viatris Pharmaceuticals Holding B.V. Netherlands Viatris Philippines Holding B.V. Netherlands Viatris Spain Holding B.V. Netherlands Viatris Turkey Holding B.V. Norway Viatris AS Norway ZpearPoint AS Poland Mylan EPD Sp. z o.o. Poland Mylan Healthcare Sp. z o.o. Portugal BGP Products, Unipessoal, LDA Portugal Laboratorios Anova - Produtos Farmaceuticos, LDA Portugal Laboratorios Delta, S.A. Portugal Mylan, Lda Portugal VIATRIS HEALTHCARE Lda. Romania BGP Products S.r.l. Slovakia Meda Pharma spol. s r.o. Slovakia Mylan s.r.o. Slovakia Viatris Slovakia s.r.o. Slovenia Viatris, farmacevtsko podjetje, d.o.o. Spain Fundacion Viatris para la Salud Spain Laboratorios Parke Davis, S.L. Spain Meda Pharma, S.L. Spain PEMB OFG Spain Holding, S.L. Spain Pfizer PFE Spain Holding, S.L. Spain Viatris Healthcare S.L. Spain VIATRIS PHARMACEUTICALS, S.L. Sweden Abbex AB Sweden BGP Products AB Sweden Ipex AB Sweden Ipex Medical AB Sweden Meda AB Sweden Meda OTC AB Sweden Mylan AB
Sweden Mylan Sweden Holdings AB Sweden Recip AB Sweden Scandinavian Pharmaceuticals-Generics AB (SE) Sweden Viatris AB Switzerland BGP Products Operations GmbH Switzerland BGP Products Switzerland GmbH Switzerland MEDA Pharma GmbH Switzerland MEDA Pharmaceuticals Switzerland GmbH Switzerland Mylan Pharma GmbH Switzerland TAP Pharmaceuticals AG Switzerland Viatris Pharma GmbH
Viatris_DPO_Appointment_Letter_Feb2023_incl- email_v2Oct2023 Final Audit Report 2023-10-10
Created: 2023-10-10
By: joanna bertier ([email protected])
Status: Signed
Transaction ID: CBJCHBCAABAA1TNl7mQ0oz8Wgz0YXBUEaPdJ59Fsamnn
"Viatris_DPO_Appointment_Letter_Feb2023_incl-email_v2Oct20 23" History
Document created by joanna bertier ([email protected]) 2023-10-10 - 2:37:32 PM GMT
Document emailed to [email protected] for signature 2023-10-10 - 2:38:13 PM GMT
Email viewed by [email protected] 2023-10-10 - 7:39:14 PM GMT
Signer [email protected] entered name at signing as Tracey Basler 2023-10-10 - 7:40:37 PM GMT
Document e-signed by Tracey Basler ([email protected]) Signature Date: 2023-10-10 - 7:40:39 PM GMT - Time Source: server
Agreement completed. 2023-10-10 - 7:40:39 PM GMT
Global Data Privacy 1000 Mylan Boulevard Canonsburg, PA 15317
To: Supervisory Authority Data Protection Office January 31, 2023 Appointment of EU Data Protection Officer Dear Supervisory Authority, In accordance with Article 37(7) of the GDPR, please find below the Data Protection Officer that will be appointed for the European undertakings outlined in Appendix 1. The contact details for the Data Protection Officer are: Tracey Basler Head of Global Privacy, 1000 Mylan Boulevard, Canonsburg, PA 15317, United States e-mail: [email protected] The EU-based contact supporting the Data Protection Officer is: Joanna Zielinska-Bertier Senior Data Privacy Manager for Europe 1 rue de Turin 69007 Lyon, France e-mail : [email protected] Best regards,
X Tracey Basler Head of Global Privacy
Tracey Basler (Oct 10, 2023 15:40 EDT) Tracey Basler
Appendix 1
Jurisdiction Company Name Austria Arcana Arzneimittel GmbH Austria Mylan Österreich GmbH Belgium Pfizer Innovative Supply Point International BV Belgium Upjohn SRL Belgium Viatris BV
Belgium Viatris GX BV Belgium Viatris Healthcare NV Bosnia and Herzegovina Viatris BH, društvo sa ograničenom odgovornošću za trgovinu i usluge Bulgaria Mylan EOOD Croatia Viatris Hrvatska d.o.o. Cyprus Agila Specialties (Holdings) Cyprus Limited (in liquidation) Cyprus Agila Specialties Americas Limited (in liquidation) Cyprus Onco Laboratories Limited Czech Republic MEDA Pharma s.r.o. Czech Republic Mylan Pharmaceuticals s.r.o. Czech Republic Viatris CZ s.r.o. Denmark Mylan ApS Denmark Viatris ApS England & Wales Agila Specialties Investments Ltd England & Wales Generics (U.K.) Ltd. England & Wales Mylan Holdings Ltd. England & Wales Mylan Pharma UK Limited England & Wales Mylan Products Limited England & Wales Upjohn UK 2 Ltd. England & Wales Upjohn UK Limited England & Wales Viatris UK Healthcare Limited Estonia Viatris OÜ
Finland Viatris Oy France Laboratoires Madaus S.A.S.
France Meda Holding S.A.S. France Meda Manufacturing S.A.S. France Meda Pharma S.A.S. France Mylan Generics France Holding S.A.S. France Mylan Laboratories S.A.S. France Rottapharm S.A.S. France VIATRIS HEALTHCARE France VIATRIS MEDICAL France VIATRIS SANTE France VIATRIS UP Germany Erste Madaus Beteiligungs GmbH
Germany MEDA Germany Holding GmbH Germany MEDA Manufacturing GmbH Germany MWB Pharma GmbH Germany Mylan dura GmbH Germany Pharmazeutische Union GmbH Germany PharmLog Pharma Logistik GmbH Germany ROTTAPHARM | MADAUS GmbH Germany VIATRIS GmbH Germany Viatris Pharma GmbH Germany Zweite Madaus Beteiligungs GmbH Greece Viatris Hellas Limited Liability Company Hungary Viatris Healthcare Kft. Hungary Viatris Services Kft. Ireland McDermott Laboratories Limited Ireland Meda Health Sales Ireland Limited Ireland Mylan IRE Healthcare Limited Ireland Mylan Ireland Limited Ireland Mylan Pharma Acquisition Limited Ireland Mylan Pharmaceuticals Limited Ireland Mylan Teoranta Ireland Rottapharm Limited Ireland Upjohn Manufacturing Ireland Unlimited Ireland Viatris Healthcare Limited Ireland Viatris Limited Italy DERMOGROUP S.r.l. Italy Meda Pharma S.p.A. Italy Mylan S.p.A. Italy Rottapharm S.p.A.
Italy Viatris Italia S.r.l. Italy Viatris Pharma S.r.l. Latvia SIA "Meda Pharma" Latvia Viatris SIA Lithuania Viatris UAB Netherlands Meda Pharma B.V. Netherlands Mylan B.V. Netherlands Mylan Group B.V. Netherlands Mylan Healthcare B.V. Netherlands Mylan I B.V. in liquidatie Netherlands Mylan II B.V. Netherlands Upjohn Belgium B.V. Netherlands Upjohn EESV Netherlands Upjohn Europe Holdings B.V. Netherlands Upjohn Export B.V.
Netherlands Upjohn Finance B.V. Netherlands Upjohn Global Holdings B.V. Netherlands Upjohn Group Holdings B.V. Netherlands Upjohn Intermediate Holdings B.V. Netherlands Upjohn International Holdings B.V. Netherlands Upjohn Vietnam Dutch B.V. Netherlands Viatris Enterprise Holding B.V. Netherlands Viatris Ireland Holding B.V. Netherlands Viatris Manufacturing B.V. Netherlands Viatris Mexico Holding B.V. Netherlands Viatris Netherlands B.V. Netherlands Viatris Pharmaceuticals Holding B.V. Netherlands Viatris Philippines Holding B.V. Netherlands Viatris Spain Holding B.V. Netherlands Viatris Turkey Holding B.V. Norway Viatris AS Norway ZpearPoint AS Poland Mylan EPD Sp. z o.o. Poland Mylan Healthcare Sp. z o.o. Portugal BGP Products, Unipessoal, LDA Portugal Laboratorios Anova - Produtos Farmaceuticos, LDA Portugal Laboratorios Delta, S.A. Portugal Mylan, Lda Portugal VIATRIS HEALTHCARE Lda. Romania BGP Products S.r.l. Slovakia Meda Pharma spol. s r.o. Slovakia Mylan s.r.o. Slovakia Viatris Slovakia s.r.o. Slovenia Viatris, farmacevtsko podjetje, d.o.o. Spain Fundacion Viatris para la Salud Spain Laboratorios Parke Davis, S.L. Spain Meda Pharma, S.L. Spain PEMB OFG Spain Holding, S.L. Spain Pfizer PFE Spain Holding, S.L. Spain Viatris Healthcare S.L. Spain VIATRIS PHARMACEUTICALS, S.L. Sweden Abbex AB Sweden BGP Products AB Sweden Ipex AB Sweden Ipex Medical AB Sweden Meda AB Sweden Meda OTC AB Sweden Mylan AB
Sweden Mylan Sweden Holdings AB Sweden Recip AB Sweden Scandinavian Pharmaceuticals-Generics AB (SE) Sweden Viatris AB Switzerland BGP Products Operations GmbH Switzerland BGP Products Switzerland GmbH Switzerland MEDA Pharma GmbH Switzerland MEDA Pharmaceuticals Switzerland GmbH Switzerland Mylan Pharma GmbH Switzerland TAP Pharmaceuticals AG Switzerland Viatris Pharma GmbH
Viatris_DPO_Appointment_Letter_Feb2023_incl- email_v2Oct2023 Final Audit Report 2023-10-10
Created: 2023-10-10
By: joanna bertier ([email protected])
Status: Signed
Transaction ID: CBJCHBCAABAA1TNl7mQ0oz8Wgz0YXBUEaPdJ59Fsamnn
"Viatris_DPO_Appointment_Letter_Feb2023_incl-email_v2Oct20 23" History
Document created by joanna bertier ([email protected]) 2023-10-10 - 2:37:32 PM GMT
Document emailed to [email protected] for signature 2023-10-10 - 2:38:13 PM GMT
Email viewed by [email protected] 2023-10-10 - 7:39:14 PM GMT
Signer [email protected] entered name at signing as Tracey Basler 2023-10-10 - 7:40:37 PM GMT
Document e-signed by Tracey Basler ([email protected]) Signature Date: 2023-10-10 - 7:40:39 PM GMT - Time Source: server
Agreement completed. 2023-10-10 - 7:40:39 PM GMT